KR101270908B1 - 솔리페나신 또는 그의 염의 고형 제제용 조성물 - Google Patents
솔리페나신 또는 그의 염의 고형 제제용 조성물 Download PDFInfo
- Publication number
- KR101270908B1 KR101270908B1 KR1020127004903A KR20127004903A KR101270908B1 KR 101270908 B1 KR101270908 B1 KR 101270908B1 KR 1020127004903 A KR1020127004903 A KR 1020127004903A KR 20127004903 A KR20127004903 A KR 20127004903A KR 101270908 B1 KR101270908 B1 KR 101270908B1
- Authority
- KR
- South Korea
- Prior art keywords
- solifenacin
- salt
- amorphous
- solvent
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (11)
- 솔리페나신 또는 그의 염의 결정체를 함유하고, 솔리페나신 또는 그의 염의 비정질체 함유량이 77 % 이하이며, 솔리페나신 또는 그의 염의 결정체와 솔리페나신 또는 그의 염의 비정질체 및 이들의 분해물의 총량에 대한 솔리페나신의 주분해물의 양은 0.4% 이하인 솔리페나신 또는 그의 염의 정제의 제조 방법으로서, 상기 방법이
(i) 용매를 사용하지 않고 솔리페나신 또는 그의 염과 부형제를 배합하여 압축 성형하는 공정;
(ii) 솔리페나신 또는 그의 염에 용매를 습식 조립시에 첨가하는 공정 (용매 1 mL에 대하여 솔리페나신 또는 그의 염이 녹는 양이 0.1 mg 미만임); 또는
(iii) 솔리페나신 또는 그의 염을 비정질화시키는 용매를 습식 조립시에 첨가시키는 공정 (용매 1 mL에 대하여 솔리페나신 또는 그의 염이 녹는 양이 10 mg 이상임)
을 포함하는 것인 제조 방법. - 제1항에 있어서, 공정 (ii)의 용매가 아세톤 또는 헥산 또는 이들의 혼합물을 포함하는 것인 제조 방법.
- 제1항에 있어서, 공정 (iii)의 용매가 물, 메탄올 또는 에탄올 또는 이들의 혼합물을 포함하는 것인 제조 방법.
- 제3항에 있어서,결합제가 상기 공정 (iii)의 용매에 용해되고 그 용액을 분무하는 단계를 포함하며, 여기서 분무 중의 과립의 수분치가 9% 이하인 방법.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 비정질체의 솔리페나신 또는 그의 염의 결정화를 촉진 처리하는 공정을 추가로 포함하는 것인 방법.
- 제5항에 있어서, 결정화를 촉진 처리하는 공정이 가온 처리, 가습 처리, 가온 및 가습 처리, 마이크로파 조사 처리, 저주파 조사 처리, 초음파 조사 처리 및 열 전자 조사 처리로 이루어진 군에서 선택되는 하나 이상의 공정인 방법.
- 제6항에 있어서, 가온 처리, 가습 처리, 또는 가온 및 가습 처리하는 공정이 항온 항습기 중에서 25 ℃, 75 %RH 조건하에서 1 주간 정치 후 재건조시키는 공정을 포함하는 것인 방법.
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55602504P | 2004-03-25 | 2004-03-25 | |
US60/556,025 | 2004-03-25 | ||
US63838804P | 2004-12-27 | 2004-12-27 | |
US60/638,388 | 2004-12-27 | ||
PCT/JP2005/005377 WO2005092889A1 (ja) | 2004-03-25 | 2005-03-24 | ソリフェナシンまたはその塩の固形製剤用組成物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067019783A Division KR20070010132A (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020137006732A Division KR20130041346A (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120030597A KR20120030597A (ko) | 2012-03-28 |
KR101270908B1 true KR101270908B1 (ko) | 2013-06-03 |
Family
ID=35056127
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067019783A KR20070010132A (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
KR1020137006732A KR20130041346A (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
KR1020117007484A KR101156406B1 (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
KR1020127004903A KR101270908B1 (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
KR1020147008466A KR101836467B1 (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067019783A KR20070010132A (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
KR1020137006732A KR20130041346A (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
KR1020117007484A KR101156406B1 (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020147008466A KR101836467B1 (ko) | 2004-03-25 | 2005-03-24 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
Country Status (19)
Country | Link |
---|---|
US (2) | US8039482B2 (ko) |
EP (2) | EP1728791A4 (ko) |
JP (3) | JP5168711B2 (ko) |
KR (5) | KR20070010132A (ko) |
AU (1) | AU2005226357B2 (ko) |
BG (2) | BG1639U1 (ko) |
BR (1) | BRPI0509062A (ko) |
CA (1) | CA2561167C (ko) |
CZ (2) | CZ23090U1 (ko) |
DK (1) | DK2156824T3 (ko) |
ES (1) | ES2397307T3 (ko) |
IL (1) | IL178249A (ko) |
MX (1) | MXPA06010908A (ko) |
NO (1) | NO340020B1 (ko) |
PL (1) | PL2156824T3 (ko) |
PT (1) | PT2156824E (ko) |
RU (1) | RU2359670C2 (ko) |
SK (2) | SK6199Y1 (ko) |
WO (1) | WO2005092889A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180125664A (ko) | 2017-05-15 | 2018-11-26 | 주식회사 서울제약 | 솔리페나신을 유효성분으로 하는 구강붕해필름 |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050175689A1 (en) * | 2003-10-27 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | Coated fine particles containing drug for intrabuccally fast disintegrating tablet |
KR20070010132A (ko) | 2004-03-25 | 2007-01-22 | 아스텔라스세이야쿠 가부시키가이샤 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
EP1832288B1 (en) * | 2004-12-27 | 2012-06-20 | Astellas Pharma Inc. | Stable granular pharmaceutical composition of solifenacin or its salt |
EP1852117A4 (en) * | 2005-02-25 | 2010-10-27 | Astellas Pharma Inc | PHARMACEUTICAL AGENT COMPRISING SOLIFENACIN |
US7815939B2 (en) * | 2005-07-20 | 2010-10-19 | Astellas Pharma Inc. | Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms |
US20080114029A1 (en) * | 2006-08-03 | 2008-05-15 | Tamas Koltai | Polymorphs of solifenacin intermediate |
EP2018850A1 (en) * | 2007-07-24 | 2009-01-28 | Ratiopharm GmbH | Pharmaceutical composition comprising solifenacin or a pharmaceutically acceptable salt thereof |
EP2210595A1 (en) * | 2009-01-14 | 2010-07-28 | LEK Pharmaceuticals d.d. | Active coating of pharmaceutical dosage forms |
SI2400954T1 (sl) | 2009-02-27 | 2017-02-28 | Krka, D.D., Novo Mesto | Postopek za pripravo trdne oralne dozirne oblike solifenacina in njegovih farmacevtsko sprejemljivih soli |
US20100273825A1 (en) * | 2009-03-30 | 2010-10-28 | Astellas Pharma Inc. | Solid pharmaceutical composition containing solifenacin amorphous form |
EA201291189A1 (ru) | 2010-05-07 | 2013-05-30 | Зентива К.С. | Фармацевтическая композиция, содержащая солифенацин, и способ его получения |
US9918970B2 (en) | 2010-05-19 | 2018-03-20 | Astellas Pharma Inc. | Pharmaceutical composition comprising solifenacin |
EP2590973B1 (en) | 2010-07-05 | 2016-08-31 | Crystal Pharma, S.A.U. | Solifenacin salts |
US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
EP2680694B1 (en) | 2011-02-28 | 2019-01-02 | BioMarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
EP2500013B1 (en) | 2011-03-15 | 2019-10-02 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical composition comprising solifenacin |
CA2835277A1 (en) * | 2011-05-10 | 2012-11-15 | Theravida, Inc. | Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder |
TWI500223B (zh) * | 2012-09-17 | 2015-09-11 | Delta Electronics Inc | Rj連接器的端子結構、應用其之rj連接器模組及rj連接器系統 |
EP2778167A1 (en) | 2013-03-11 | 2014-09-17 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt |
CA2930199C (en) * | 2013-11-12 | 2022-10-25 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases |
KR20150092385A (ko) | 2014-02-03 | 2015-08-13 | 씨제이헬스케어 주식회사 | 솔리페나신을 포함하는 안정한 제제 및 이의 제조방법 |
KR20150102852A (ko) * | 2014-02-28 | 2015-09-08 | 대원제약주식회사 | 무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법 |
JP2015189677A (ja) * | 2014-03-27 | 2015-11-02 | テバ製薬株式会社 | ソリフェナシン非晶質体を含有する医薬組成物 |
WO2015170237A1 (en) * | 2014-05-05 | 2015-11-12 | Torrent Pharmaceuticals Limited | Stable solifenacin composition |
WO2016100152A1 (en) * | 2014-12-19 | 2016-06-23 | Merck Sharp & Dohme Corp. | (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations |
JP6639024B2 (ja) * | 2016-04-08 | 2020-02-05 | 大原薬品工業株式会社 | 化学的な安定性を改善した、非晶質体ソリフェナシン含有製剤 |
KR20180003340A (ko) * | 2016-06-30 | 2018-01-09 | 한미약품 주식회사 | 무정형 솔리페나신 함유 경구용 고형제제 및 그 제조방법 |
JP6805699B2 (ja) * | 2016-10-04 | 2020-12-23 | ニプロ株式会社 | 医薬組成物、医薬組成物の製造方法、及び非晶質体の安定性を向上させる方法 |
JP6792418B2 (ja) * | 2016-11-08 | 2020-11-25 | 日本化薬株式会社 | カペシタビンを有効成分とする医薬製剤の製造方法 |
US20200022910A1 (en) | 2017-02-24 | 2020-01-23 | Ftf Pharma Private Limited | Pharmaceutical composition of oral solution of muscarinic antagonist |
EP4035660A1 (en) * | 2017-10-17 | 2022-08-03 | Synthon B.V. | Tablets comprising tamsulosin and solifenacin |
UY38137A (es) | 2018-03-08 | 2019-07-31 | Intas Third Party Sales 2005 S L | Una forma de dosificación oral sólida farmacéutica de solifenacina |
KR20200077268A (ko) | 2018-12-20 | 2020-06-30 | 충북대학교 산학협력단 | 솔리페나신 타르타르산염의 구강 투여용 약학 제제로서의 용도 |
KR20210114271A (ko) | 2020-03-10 | 2021-09-23 | 주식회사 종근당 | 솔리페나신 또는 이의 약제학적으로 허용가능한 염을 함유하는 약제학적 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996020194A1 (fr) | 1994-12-28 | 1996-07-04 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveaux derives de quinuclidine et composition pharmaceutique les contenant |
WO2003103659A1 (ja) | 2002-06-07 | 2003-12-18 | 山之内製薬株式会社 | 過活動膀胱治療剤 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4573140A (en) | 1983-03-30 | 1986-02-25 | Voicetek Corporation | Method of and apparatus for voice communication storage and forwarding with simultaneous access to multiple users |
JPS62136240A (ja) * | 1985-12-11 | 1987-06-19 | Hayashibara Biochem Lab Inc | 脱水剤及びそれを用いる含水物の脱水方法 |
US4870059A (en) | 1985-11-27 | 1989-09-26 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Dehydration of hydrous matter with anhydrous maltose |
US5082669A (en) | 1989-07-20 | 1992-01-21 | Dainippon Pharmaceutical Co., Ltd. | Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
US5075114A (en) | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
CA2052679C (en) | 1990-08-30 | 1997-12-02 | Edward J. Roche | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
US5260072A (en) | 1990-08-30 | 1993-11-09 | Mcneil-Ppc, Inc. | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
JP2841857B2 (ja) * | 1990-11-29 | 1998-12-24 | 田辺製薬株式会社 | 長期間安定な経口用医薬製剤 |
YU48263B (sh) | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
TW284688B (ko) | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd | |
JP2682353B2 (ja) | 1991-11-20 | 1997-11-26 | 武田薬品工業株式会社 | 経口用医薬組成物およびその製造法 |
ZA938438B (en) | 1992-11-17 | 1994-06-20 | Sankyo Co | Crystalline carbapenem derivative |
KR100296810B1 (ko) | 1993-03-12 | 2001-10-24 | 로렌스 티. 마이젠헬더 | 결정성세프티오퍼유리산 |
US6011062A (en) * | 1994-12-22 | 2000-01-04 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
JPH0971764A (ja) | 1995-06-28 | 1997-03-18 | Ajinomoto Co Inc | 粉 体 |
JPH0971761A (ja) * | 1995-07-06 | 1997-03-18 | Yokohama Rubber Co Ltd:The | 絶縁耐熱性接着剤およびその製造方法 |
JPH09110698A (ja) | 1995-10-19 | 1997-04-28 | Taiho Yakuhin Kogyo Kk | 経口用医薬組成物の製造法 |
DE19612131A1 (de) | 1996-03-27 | 1998-01-22 | Hoechst Ag | Feste Arzneistoffzubereitung, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl) -anilid |
KR20000069899A (ko) | 1997-01-06 | 2000-11-25 | 디. 제이. 우드, 스피겔 알렌 제이 | 속방성 및 미각 차폐성 약제학적 용량 형태 |
DE69834255T2 (de) * | 1997-07-25 | 2006-09-28 | Alpex Pharma S.A. | Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten |
US20040136915A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing atropine |
US6221402B1 (en) | 1997-11-20 | 2001-04-24 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
JP2002104968A (ja) * | 2000-09-28 | 2002-04-10 | Senju Pharmaceut Co Ltd | 毛様体筋の緊張緩和剤 |
US20020119196A1 (en) | 2000-12-21 | 2002-08-29 | Narendra Parikh | Texture masked particles containing an active ingredient |
MXPA03009588A (es) | 2001-04-18 | 2004-12-06 | Nostrum Pharmaceuticals Inc | Un recubrimiento novedoso para una composicion farmaceutica de liberacion sostenida. |
WO2002096392A1 (en) | 2001-05-31 | 2002-12-05 | Cima Labs Inc. | Taste-masking of highly water-soluble drugs |
WO2003006019A1 (fr) | 2001-07-10 | 2003-01-23 | Yamanouchi Pharmaceutical Co., Ltd. | Composition medicinale destinee au traitement de la cystite interstitielle |
WO2003070233A1 (en) * | 2002-02-19 | 2003-08-28 | Pharmacia Corporation | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
JP4173670B2 (ja) * | 2002-03-08 | 2008-10-29 | 旭化成ファーマ株式会社 | 口腔内崩壊製剤 |
DE10224107A1 (de) | 2002-05-29 | 2003-12-11 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz |
JP2004026675A (ja) | 2002-06-21 | 2004-01-29 | Lion Corp | 咀嚼型医薬製剤用粒子、それを使用した咀嚼型医薬製剤、及び咀嚼型医薬製剤の不快味抑制方法 |
BR0315784A (pt) * | 2002-10-29 | 2005-09-20 | Pharmacia & Upjohn Co Llc | Compostos de amÈnio quaternário |
JP4523265B2 (ja) * | 2002-11-13 | 2010-08-11 | 旭化成ファーマ株式会社 | 排尿障害治療用口腔内崩壊製剤 |
BRPI0408608A (pt) * | 2003-03-21 | 2006-03-07 | Dynogen Pharmaceuticals Inc | uso de moduladores da subunidade (alfa)2(delta) de canal de cálcio e moduladores de músculo liso para tratamento de sintoma de um distúrbio do trato urinário inferior |
US20060147531A1 (en) | 2003-07-01 | 2006-07-06 | Mojca Segula | Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate |
EP1679066A4 (en) | 2003-10-27 | 2011-06-22 | Astellas Pharma Inc | MEDICINAL COATING MICROPARTICLES FOR A MOUTH-DISABLE TABLET |
US20050175689A1 (en) | 2003-10-27 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | Coated fine particles containing drug for intrabuccally fast disintegrating tablet |
US20080287680A1 (en) * | 2004-02-09 | 2008-11-20 | Astellas Pharma Inc. | Solifenacin Succinate-Containing Composition |
WO2005077364A1 (ja) * | 2004-02-18 | 2005-08-25 | Yamanouchi Pharmaceutical Co., Ltd. | ソリフェナシンの経皮投与製剤およびその経皮透過改善方法 |
CA2560080A1 (en) | 2004-03-16 | 2005-09-22 | Astellas Pharma Inc. | Solifenacin-containing composition |
KR20070010132A (ko) | 2004-03-25 | 2007-01-22 | 아스텔라스세이야쿠 가부시키가이샤 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
EP1832288B1 (en) * | 2004-12-27 | 2012-06-20 | Astellas Pharma Inc. | Stable granular pharmaceutical composition of solifenacin or its salt |
US7815939B2 (en) | 2005-07-20 | 2010-10-19 | Astellas Pharma Inc. | Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms |
-
2005
- 2005-03-24 KR KR1020067019783A patent/KR20070010132A/ko not_active Application Discontinuation
- 2005-03-24 KR KR1020137006732A patent/KR20130041346A/ko not_active Application Discontinuation
- 2005-03-24 KR KR1020117007484A patent/KR101156406B1/ko active IP Right Grant
- 2005-03-24 PT PT90145004T patent/PT2156824E/pt unknown
- 2005-03-24 DK DK09014500.4T patent/DK2156824T3/da active
- 2005-03-24 JP JP2006511497A patent/JP5168711B2/ja not_active Expired - Fee Related
- 2005-03-24 SK SK5020-2011U patent/SK6199Y1/sk unknown
- 2005-03-24 SK SK5022-2011U patent/SK50222011U1/sk unknown
- 2005-03-24 PL PL09014500T patent/PL2156824T3/pl unknown
- 2005-03-24 CZ CZ201124174U patent/CZ23090U1/cs not_active IP Right Cessation
- 2005-03-24 WO PCT/JP2005/005377 patent/WO2005092889A1/ja active Application Filing
- 2005-03-24 CZ CZ201124172U patent/CZ23088U1/cs not_active IP Right Cessation
- 2005-03-24 KR KR1020127004903A patent/KR101270908B1/ko active IP Right Review Request
- 2005-03-24 RU RU2006137565/15A patent/RU2359670C2/ru active
- 2005-03-24 EP EP05721391A patent/EP1728791A4/en not_active Withdrawn
- 2005-03-24 BR BRPI0509062-8A patent/BRPI0509062A/pt not_active Application Discontinuation
- 2005-03-24 CA CA2561167A patent/CA2561167C/en not_active Expired - Fee Related
- 2005-03-24 ES ES09014500T patent/ES2397307T3/es active Active
- 2005-03-24 MX MXPA06010908A patent/MXPA06010908A/es active IP Right Grant
- 2005-03-24 EP EP09014500A patent/EP2156824B1/en not_active Not-in-force
- 2005-03-24 KR KR1020147008466A patent/KR101836467B1/ko not_active IP Right Cessation
- 2005-03-24 AU AU2005226357A patent/AU2005226357B2/en not_active Ceased
- 2005-03-24 US US10/594,127 patent/US8039482B2/en not_active Expired - Fee Related
-
2006
- 2006-09-21 IL IL178249A patent/IL178249A/en active IP Right Review Request
- 2006-10-24 NO NO20064830A patent/NO340020B1/no not_active IP Right Cessation
-
2010
- 2010-03-05 JP JP2010049166A patent/JP5177156B2/ja not_active Expired - Fee Related
- 2010-11-19 US US12/950,492 patent/US20110065746A1/en not_active Abandoned
-
2011
- 2011-04-12 BG BG1969U patent/BG1639U1/bg unknown
- 2011-04-12 BG BG1968U patent/BG1638U1/bg unknown
-
2012
- 2012-10-17 JP JP2012229790A patent/JP2013040193A/ja not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996020194A1 (fr) | 1994-12-28 | 1996-07-04 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveaux derives de quinuclidine et composition pharmaceutique les contenant |
WO2003103659A1 (ja) | 2002-06-07 | 2003-12-18 | 山之内製薬株式会社 | 過活動膀胱治療剤 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180125664A (ko) | 2017-05-15 | 2018-11-26 | 주식회사 서울제약 | 솔리페나신을 유효성분으로 하는 구강붕해필름 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101270908B1 (ko) | 솔리페나신 또는 그의 염의 고형 제제용 조성물 | |
EP1832288B1 (en) | Stable granular pharmaceutical composition of solifenacin or its salt | |
JP4816828B2 (ja) | ソリフェナシン非晶質体を含有した固形医薬組成物 | |
JP2013079234A (ja) | N−メチル−2−[3−((e)−2−ピリジン−2−イル−ビニル)−1h−インダゾール−6−イルスルファニル]−ベンズアミドの医薬組成物 | |
TWI756177B (zh) | 安定的經口投予用醫藥組成物 | |
ZA200608614B (en) | Composition for solid pharmaceutical preparation of solifenacin or salt thereof | |
BG1677U1 (bg) | Фармацевтичен състав със стабилни частици на солифенацин или негова сол | |
JPWO2008143241A1 (ja) | 医薬錠剤の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
A107 | Divisional application of patent | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
J206 | Request for trial to confirm the scope of a patent right | ||
FPAY | Annual fee payment |
Payment date: 20160427 Year of fee payment: 4 |
|
J206 | Request for trial to confirm the scope of a patent right | ||
J206 | Request for trial to confirm the scope of a patent right | ||
FPAY | Annual fee payment |
Payment date: 20170504 Year of fee payment: 5 |
|
J121 | Written withdrawal of request for trial | ||
J204 | Request for invalidation trial [patent] | ||
J204 | Request for invalidation trial [patent] | ||
J121 | Written withdrawal of request for trial | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2016100001997; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160708 Effective date: 20180419 Free format text: TRIAL NUMBER: 2017100001325; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170426 Effective date: 20180419 Free format text: TRIAL NUMBER: 2017100001327; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170426 Effective date: 20180419 Free format text: TRIAL NUMBER: 2017100001326; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170426 Effective date: 20180419 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2017100002150; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002151; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002146; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100001545; TRIAL DECISION FOR INVALIDATION REQUESTED 20170518 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002147; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002148; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002149; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002153; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002152; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002154; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002140; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002136; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002135; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002141; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002137; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002138; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002143; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002139; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002142; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002145; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 Free format text: TRIAL NUMBER: 2017100002144; TRIAL DECISION FOR INVALIDATION REQUESTED 20170707 Effective date: 20180720 |
|
G170 | Re-publication after modification of scope of protection [patent] | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
G170 | Re-publication after modification of scope of protection [patent] |